0      0


AM21-46: Oral Abstract Session -- Transfusion Medicine and Cellular Therapy Innovation


‐ Oct 19, 2021 3:45pm

Expiration Date: Dec 31, 2023


Credits: None available.

Oral abstract session focused on Transfusion Medicine and Cellular Therapy Innovation.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:

  • List demographic factors that impact anti-COVID-19 antibody levels in convalescent plasma donors.
  • Describe the qualities of antibody responses in blood donors who either had a prior COVID-19 infection or were vaccinated against COVID-19.
  • List proteomic markers that improve engraftment potential of fetal liver-derived hematopoietic stem cells.
  • Discuss steps that can be taken to improve survival of biotinylated red blood cells.

Moderator(s):

Speaker(s):

Disclosures

  • Kim Vanuytsel:
    Consultant: CSL Plasma
  • Amy Schmidt, MD, PhD:
    Consultant: CSL Plasma
  • Thomas Gniadek, MD, PHD:
    Consultant: Fresenius Kabi

By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available


AM21-46: Oral Abstract Session -- Transfusion Medicine and Cellular Therapy Innovation Evaluation